{"name":"ProMis Neurosciences, Inc","slug":"promis-neurosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQREstRW1wM0FGcy1HTUhaTHlkR1NBRkpvMjBIQ3dHQk9pX29pb1FxYnpZdVRYZ1hCdTRiVmJMYTJjSWhkdkVlcWFfMnNDM0tCbHFQT3d4NXkzcE1PMGhYbFZkdkNXMDRKN0t5N21uWERFVmNLTkd2X2xkX29WVk9yRXpLaVRRMkVCWnFfUElqVHNTa09CSms1SlNGVkwwbk5yWU5VekR5aFo4bEY4eHRQMVlYci1nSzdWV1BsSnZFMFhUTTlNSE5STEJGWlpsTmtjREpHZDJ6MTZJS25GUEFDMmU3TUhyOFV1N1RPc2ZoVzFDd20tMFlpWWdqY1pzUQ?oc=5","date":"2026-03-25","type":"pipeline","source":"globenewswire.com","summary":"ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights - globenewswire.com","headline":"ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1hZjBnNG1NUGdlZkFwVll3T0ZiMmM4eE0xWTU1anVwMUpNMWhiUGp2TlhCQ3piQThocDhtQkVRa0JPV2xWUTNIY0ZTUnB0Snhwcmh4c0dqaTZLZ3ozWDB1eWtfZlZRYjV2TG05eg?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Promis Neuroscie (PMN) - Stock Titan","headline":"If You Invested $1,000 in Promis Neuroscie (PMN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPbWRGcV9kMUZYcUR4ZUppZ2UwQlRneFJTUnBkLUoxTEw5MnA5Q2pQMXc1d1Z5RmZUdkt2SDA2ajFZQXAxN3hxZGNKZXJIRkZFdWZKUmIxb0JtS0RlTmZlNGQ3QThzYUhtMTlPOG5Gd3VsYUlHVGYydWZyUFE3YTJ2NXhWM1NfZkdfYUpfZnEwTjdFQmpDeHp3NTNoWk5FNU1ieVA3T2Ryd2pfZnBFY1hPWVVjeWl0YWpiMXliak51dWtMQnFLMXNxOHhn?oc=5","date":"2026-03-18","type":"pipeline","source":"Stock Titan","summary":"Wellington holds 9.99% of ProMIS Neurosciences (NASDAQ: PMN) via shares and warrants - Stock Titan","headline":"Wellington holds 9.99% of ProMIS Neurosciences (NASDAQ: PMN) via shares and warrants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOQmhUU0ZNLUxxaGUycmdqbXJZeEtHWnFpOVhMT0xCSzhoaUdac2ZiN2JVc0hudUxfZ01lOEloNTVRbFM0em1GRmRic0k0RVdPVEZnZlYzXzNhbDlYa2F5amNZeVZfQXRJbXR6eHJ4SmtPOHdOQi1QSm5yMmZkcWl5cHFZbzRlNGJKdVFvMjc4SEJnYXBXamVoZE1tdWhib0Z0NlJaQlNvTEFaRmRhU0FpR3Yxa0xna1g4Umc?oc=5","date":"2026-03-06","type":"pipeline","source":"Stock Titan","summary":"ProMIS Neurosciences (PMN) director purchases 2,000 common shares in open market - Stock Titan","headline":"ProMIS Neurosciences (PMN) director purchases 2,000 common shares in open market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1IMzdJWGZmZ3FUZjNOZW5lWDRSNlMtV0U1WkMyN3VHTURSMWgzSnhpWjBuMm5lc1lZTDJoOFhpZnNqQlo0Ukxwd3Z0T1dZZVhBOEt1dDdsTU11RUJjVnVQY2tCcnZjNzk5bFVPRGd5X1RuTTRRTTlTdTdB?oc=5","date":"2026-02-19","type":"trial","source":"statnews.com","summary":"What to expect from Gossamer Bio’s late-stage lung disease study - statnews.com","headline":"What to expect from Gossamer Bio’s late-stage lung disease study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNUS1MbDRJZ0pyZHVscEdUcHplWVpiVHprNUxRT3ByYnNiNVhieDFoZFFEVVJoQkk0a2NVRVA4c0s4NE9ZWWxmaGpNQ2hHdVlOLTBqNEU5NC1sdk44Q1g2OVIwcUlqZ1NJMlNvcDlBNVdwVHpDc280MHplNjFuTTQyWW0xUURwRkIzYTl1Y1cxLU9Cck5Ld0xNU2ppclBPMkE0aHE2bS1pZHVzOXNDU2MyNVFWWER2bVBjdUxsTzBGYXlxY2lycDdYR2Z4YzRPLTdIdDR0bzFSczVhTzBWWXg5Wnp3?oc=5","date":"2026-01-30","type":"pipeline","source":"globenewswire.com","summary":"ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing - globenewswire.com","headline":"ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFA3czdwNmR5WkQ5cHJ5eFkwNEZWYU5OVnBuVlpEcDdRMVF4bmRLbEJfU0NNTFdhczZVeXkyYmEzaHo4czFSNzFuV0ppZE9FdC1BMXpBb3c0RlB3VXV0YXJUOHhR?oc=5","date":"2026-01-19","type":"pipeline","source":"Labiotech.eu","summary":"10 promising biotechs racing toward a cure for ALS - Labiotech.eu","headline":"10 promising biotechs racing toward a cure for ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMldaVnppemhPRkVIMktmSXp4MVVhNVBuX3NDQ1JaZXRRZDE5RUEydnc0aTVRUUt3ek9EdmRzamtzZEd1SzlvSC1zM3hZVTVlVHN0WWlXNTVSQ0NfYTl6VTMzQkQwX3RGckpwTm00QjRqZ2dRWlZ5dHFzZlowZHY1Q0k2VkphREEtc2JXQXBSX2R5WW9s?oc=5","date":"2025-12-01","type":"trial","source":"Yahoo Finance","summary":"ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310 - Ya","headline":"ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzhe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQQlpFZWp0dUJLOFlSekFmdlpvNjlLQm5zVGJtSmpmaENIZDFhSVZVNGRiclpwdFQwRjN1YmpXaVdUT0g2cVBqUVplTUdjOUJLb0g0T0RaeVdDcUNHSVVtUTQ2dFMzQmJWVXZxc3R6OEFPQUlzM0pkZ3UwOUgzY0JVQ3RWT2FHR0FTVEZzbm43ZDFOd3lZS3NLWmhiNG53MW1KdUdVTnFyOXFUMFpLNnhYemJ1cnpyRWRKNGpiSk9rVEtDMHFkcWl0Q2puRTcwQUVvb0gySzllVW5kdDFpSmxIVGtkZzR0bTVs0gHuAUFVX3lxTE9ONlFwUC0xUHlpQWs5SjJmaFdhbzNRUGFmUnFFWHJRbmZ3STYzaEllZ2xwM3ZVeFlHVjM0OGpwNjlrWEJKbnRmMEdmVGJGVWM1Q0N5ZHJqRzBwUjQwZWpYNHRtNHRtWWZHanJzeUhEQVkxSDBxZVZPVU84ZEJoQ2pzNms2OC1EQWJaNzVIdU0tbjNYZFY4R3RCMjM1bDR2bXF0dEVVNFVmSURXamEtaWVVU0xITkw2Z0k5TjM3OEtxZGQ3ZEYxeXBqNHJObmdxTUxDeFFFQlNORXdHQThoOXFGQnNaNlp6dThpOW9IcVE?oc=5","date":"2025-11-24","type":"pipeline","source":"simplywall.st","summary":"ProMIS Neurosciences (NASDAQ:PMN) Will Have To Spend Its Cash Wisely - simplywall.st","headline":"ProMIS Neurosciences (NASDAQ:PMN) Will Have To Spend Its Cash Wisely","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxPMWFfdUdkZnA3ZXZoLWplUjFseUhrVDVJUTA0aGhXa2pRbXBzSUI2bHZTRGRDUE9ydTJXVzg5d19PbjllWG1rT1BzNjlydEZPWVFfWHZ3Ykl5bGlmYTRGZFJ3eE9yVmQ3WUtrY0xac21iOVlYSzRISVlyUXg2VXdLcTFoR2FfSVNNbDN5aGU0SWl1YldGYlhIU1dNMmV4OE5ka3dQazNjd1JlQW0tT0dKTUdKVkplN3FZU3gtSlk1NlN4MWFQUkxxY3I5bElzU2MxS3ppeGpORW5GQnl5UmVibjJpZjJPSEo2VFh2RVl5TXpxYlpaNGM0SV9GdHFmd3AzUEhCQTZibkhvR0M2U2ZWRW5ZNmtXc3E4aTBjSVlSS2lfUzRIT0lFbzVUckZjWDNsZ2JPVjBCRlRfTzhaU1FBcFVTUzU?oc=5","date":"2025-10-22","type":"pipeline","source":"globenewswire.com","summary":"ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group - globenewswire.com","headline":"ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNMVNoekV0SWpFV1lRd2JCVkU5NUhQbTVMQWZ4SDhRSjNBQnktVzBjQmh5V3FMLTgwNXRFbHItWjVKWE0yeEVldG9zLUR0TkE3b3Z3NmRON1U2Y3ZwMjBYTlk0cHloSlpoYUFsSnplNTNtbjdMREdCVC1ONGc5M0d0a3Bwb3NxNTJRZE41d2VFSEVzX3M?oc=5","date":"2025-09-03","type":"regulatory","source":"Yahoo Finance","summary":"ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310 - Yahoo Finance","headline":"ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of ","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-07-15","type":"pipeline","source":"simplywall.st","summary":"ProMIS Neurosciences Insiders Still US$234k Away From Original Investment Value - simplywall.st","headline":"ProMIS Neurosciences Insiders Still US$234k Away From Original Investment Value","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}